This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...